Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

iASPP as a regulator of immunological tolerance

Lu

Researchers from the Lu lab identify iASPP to be a key component in the anti-tumour immune response

Vacancy - Postdoctoral Researcher - Chemistry and Cancer

Jobs Shi

£34,308 - £42,155 with a discretionary range to £46,047 p.a. (pro rata)

Vacancy - Senior Postdoctoral Research Scientist - Bioinformatics

Jobs Kriaucionis Lu Schuster-Böckler Song

Grade 8: £43,414 - £51,805 with a discretionary range to £56,592 per annum

Ludwig’s Tammie Bishop awarded Associate Professorship

Ratcliffe

Congratulations to Tammie Bishop, who is made associate professor at the University of Oxford.

Pan-cancer gene signature provides insights into HIF pathway activation

Ratcliffe

Researchers from David Mole’s and Peter Ratcliffe’s laboratories establish a HIF metagene for studying hypoxia pathways.

Professor Xin Lu featured in Ludwig's Women in Science report

Lu

Ludwig Oxford’s Professor Xin Lu recounts her experiences in Ludwig Cancer Research’s special Women in Science report.

Ludwig Oxford’s Dr Parinaz Mehdipour celebrates local young scientists

Mehdipour Public Engagement

Parinaz shared insights into her career during the Science Oxford event recognising outstanding Year 13 STEM students in Oxfordshire and Buckinghamshire

Ludwig Oxford student awarded NDM graduate student prize

Lu

Dr Tom Carroll from the Lu lab receives a Highly Commended award under the NDM overall graduate student prize

Ludwig Oxford research wins Journal for ImmunoTherapy of Cancer’s best basic tumour immunology paper of 2022

Van den Eynde

A paper on a therapeutic cancer vaccine from the Van den Eynde lab was singled out for this award celebrating excellence in scientific research.

Algebraic, geometric, and topological data analysis methods enhance systems biology model of ERK kinetics.

Byrne

A mathematical analysis carried out by the Byrne group and colleagues brings new understanding to a recently published kinetic model of ERK phosphorylation.

Mechanistic insights into the ZBP1 inflammatory response

Gyrd-Hansen Lu Van den Eynde

A collaborative study, led by former Ludwig Oxford group leader Professor Mads Gyrd-Hansen, sheds light on the ZBP1-induced signalling pathway, a pathway which contributes to the viral immune response, including to SARS-CoV-2

Unexpected role of iASPP as a tumour suppressor

Lu

The Lu lab reveals that the previously characterised oncogene, iASPP, acts as a tumour suppressor in mutant RAS- and inflammation-driven skin cancers.

Two new therapeutic targets in tuft cell-like small cell lung cancer

Shi

Yang Shi’s group identify two transcriptional co-activators that are selectively important for cancer cell but not normal cell survival.

Ludwig Oxford's Yang Shi elected to National Academy of Medicine

Shi

Ludwig Cancer Research congratulates Yang Shi on one of the highest honours in the fields of health and medicine

Richard White joins Ludwig Oxford

White

It is with great pleasure that Ludwig Cancer Research announces that Richard White has joined the Oxford Branch of the Ludwig Institute for Cancer Research.

Ludwig at Oxford Open Doors 2022

Public Engagement

On Saturday 10th September 2022, the Ludwig Institute of Cancer Research participated in the Oxford Open Doors organised by the Oxford Preservation Trust.

Insights into the selectivity of an RNA methyltransferase

Shi

Research by Professor Yang Shi and colleagues sheds light on the molecular mechanism of N6-adenosine methylation by METTL4, which may be shared by related RNA methyltransferases known to be involved in cancer.

Cancer at Oxford

Barnes Boccellato Schuster-Böckler Song Van den Eynde

Read about how Oxford's experts - including Ludwig Oxford scientists - are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series

CRUK funding to investigate the molecular drivers of stomach cancer

Boccellato

Dr Francesco Boccellato wins a CRUK Early Detection and Diagnosis primer award to study tissue shape changes in the pre-cancerous stomach conditions, atrophic gastritis and intestinal metaplasia

Mathematical methods for analysing single-cell transcriptomic data

Byrne Lu

An interdisciplinary collaboration has resulted in the development of three multiscale data methods for the analysis of single-cell transcriptomic data that have advantages over current methods.

Load More